Lux Med will decide about acquisition of Swissmed shares by April 21

Lux Med signed with the main shareholder of Swissmed Centrum Zdrowia the Letter of Intent (LOI), regarding a pre-emptive right for the acquisition of Swissmed shares. The parties should sign an agreement by April 21. According to LOI, Lux Med will support Swissmed activities during the period no shorter than until July 31, 2021. Lux Med will receive pre-emption rights for the acquisition of Swissmed shares from the main shareholder. The main shareholder holds an over 50 percent stake in Swissmed, which means Lux Med may receive the controlling package.